Ellen Richmond

2.2k total citations
36 papers, 1.1k citations indexed

About

Ellen Richmond is a scholar working on Surgery, Oncology and Pharmacology. According to data from OpenAlex, Ellen Richmond has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 10 papers in Oncology and 8 papers in Pharmacology. Recurrent topics in Ellen Richmond's work include Esophageal Cancer Research and Treatment (8 papers), Inflammatory mediators and NSAID effects (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). Ellen Richmond is often cited by papers focused on Esophageal Cancer Research and Treatment (8 papers), Inflammatory mediators and NSAID effects (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). Ellen Richmond collaborates with scholars based in United States, Puerto Rico and Canada. Ellen Richmond's co-authors include Jeffrey Schlom, Kwong Y. Tsang, John L. Marshall, Jaye L. Viner, Asad Umar, MingZhu Zhu, Mary Ann Toomey, Michael Hawkins, Ping Chang and Robert J. Hoyer and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Ellen Richmond

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen Richmond United States 16 441 406 342 198 176 36 1.1k
Xianyang Yio United States 7 379 0.9× 340 0.8× 409 1.2× 347 1.8× 275 1.6× 8 1.3k
Baljinder Salh Canada 21 216 0.5× 242 0.6× 647 1.9× 135 0.7× 113 0.6× 48 1.2k
Jean‐Marie Reimund France 19 154 0.3× 264 0.7× 362 1.1× 480 2.4× 262 1.5× 58 1.4k
Ayako Yanai Japan 22 410 0.9× 394 1.0× 527 1.5× 94 0.5× 517 2.9× 43 1.6k
Ya‐Fang Huang Taiwan 20 307 0.7× 316 0.8× 532 1.6× 88 0.4× 57 0.3× 31 1.2k
Norihiro Hamamoto Japan 9 166 0.4× 183 0.5× 165 0.5× 186 0.9× 276 1.6× 18 805
Romi Ghose United States 19 397 0.9× 138 0.3× 444 1.3× 82 0.4× 85 0.5× 45 1.1k
Zahra Mojtahedi Iran 20 201 0.5× 229 0.6× 371 1.1× 107 0.5× 58 0.3× 71 859
Olivier Romano France 10 267 0.6× 82 0.2× 254 0.7× 198 1.0× 186 1.1× 14 827
Leah M. Flick United States 12 119 0.3× 358 0.9× 349 1.0× 81 0.4× 108 0.6× 15 1.0k

Countries citing papers authored by Ellen Richmond

Since Specialization
Citations

This map shows the geographic impact of Ellen Richmond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Richmond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Richmond more than expected).

Fields of papers citing papers by Ellen Richmond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Richmond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Richmond. The network helps show where Ellen Richmond may publish in the future.

Co-authorship network of co-authors of Ellen Richmond

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Richmond. A scholar is included among the top collaborators of Ellen Richmond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Richmond. Ellen Richmond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vilar, Eduardo, Jason Willis, Michael J. Hall, et al.. (2024). 638 Nous-209 vaccine induces shared neoantigen immunogenicity for cancer interception in healthy lynch syndrome carriers: results from phase Ib/II trial. Regular and Young Investigator Award Abstracts. A732–A732. 1 indexed citations
2.
Hernández, Jessica, María González‐Pons, Ricardo L. Domínguez, et al.. (2024). Establishment of a Mesoamerican–Caribbean South–South Research Platform: Challenges in the Meriva (Curcuminoids) Gastric Cancer Chemoprevention Trial. Cancer Prevention Research. 17(12). 549–555. 2 indexed citations
3.
Jacobson, Jeffrey M., David M. Zahrieh, Carrie Strand, et al.. (2022). Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection. Cancer Prevention Research. 16(3). 163–173. 11 indexed citations
4.
Hazelton, William D., Brianna N. Lauren, Steffie K. Naber, et al.. (2021). The Optimal Age to Stop Endoscopic Surveillance of Patients With Barrett’s Esophagus Based on Sex and Comorbidity: A Comparative Cost-Effectiveness Analysis. Gastroenterology. 161(2). 487–494.e4. 17 indexed citations
5.
Loomans‐Kropp, Holli A., et al.. (2020). Association of Common Use Pharmaceuticals in Reducing Risk of Esophageal Adenocarcinoma: A SEER–Medicare Analysis. Cancer Prevention Research. 14(2). 195–204. 8 indexed citations
6.
Zell, Jason A., Christine E. McLaren, Timothy R. Morgan, et al.. (2019). A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index. Cancer Prevention Research. 13(2). 203–212. 23 indexed citations
7.
Ali, Ayman, William D. Hazelton, Sonja Kroep, et al.. (2019). Optimizing Management of Patients With Barrett’s Esophagus and Low-Grade or No Dysplasia Based on Comparative Modeling. Clinical Gastroenterology and Hepatology. 18(9). 1961–1969. 19 indexed citations
8.
Wali, Ramesh K., Laura Bianchi, Sonia S. Kupfer, et al.. (2018). Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial. PLoS ONE. 13(4). e0193544–e0193544. 2 indexed citations
9.
Morgan, Timothy R., Kathryn Osann, Teodoro Bottiglieri, et al.. (2015). A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP. Cancer Prevention Research. 8(9). 864–872. 15 indexed citations
10.
Richmond, Ellen & Asad Umar. (2015). Mechanisms of esophageal adenocarcinoma formation and approaches to chemopreventive intervention. Seminars in Oncology. 43(1). 78–85. 4 indexed citations
11.
Lynch, Patrick M., Carol A. Burke, Robin Phillips, et al.. (2015). An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis. Gut. 65(2). 286–295. 75 indexed citations
12.
Chak, Amitabh, Navtej Buttar, Nathan R. Foster, et al.. (2014). Metformin Does Not Reduce Markers of Cell Proliferation in Esophageal Tissues of Patients With Barrett’s Esophagus. Clinical Gastroenterology and Hepatology. 13(4). 665–672.e4. 40 indexed citations
13.
Richmond, Ellen & Debra Dunn. (2012). Biomarkers: An Overview for Oncology Nurses. Seminars in Oncology Nursing. 28(2). 87–92. 10 indexed citations
14.
Lipkin, Steven M., J. Jack Lee, David K. Imagawa, et al.. (2011). Phase IIA Trial Testing Erlotinib as an Intervention against Intraductal Pancreatic Mucinous Neoplasms. Cancer Prevention Research. 4(4). 512–513. 4 indexed citations
15.
Sabichi, Anita L., J. Jack Lee, H. Barton Grossman, et al.. (2011). A Randomized Controlled Trial of Celecoxib to Prevent Recurrence of Nonmuscle-Invasive Bladder Cancer. Cancer Prevention Research. 4(10). 1580–1589. 42 indexed citations
16.
Lynch, Patrick M., Gregory D. Ayers, Ellen Richmond, et al.. (2010). The Safety and Efficacy of Celecoxib in Children With Familial Adenomatous Polyposis. The American Journal of Gastroenterology. 105(6). 1437–1443. 57 indexed citations
17.
Richmond, Ellen & Ann M. O’Mara. (2010). Conducting Chemoprevention Clinical Trials: Challenges and Solutions. Seminars in Oncology. 37(4). 402–406. 4 indexed citations
18.
Hawk, Ernest T., Asad Umar, Ellen Richmond, & Jaye L. Viner. (2005). Prevention and therapy of colorectal cancer. Medical Clinics of North America. 89(1). 85–110. 8 indexed citations
19.
Hawk, Ernest T., Jaye L. Viner, Ellen Richmond, & Asad Umar. (2003). Non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention. PubMed. 21. 759–789. 4 indexed citations
20.
Umar, Asad, Jaye L. Viner, Ellen Richmond, William F. Anderson, & Ernest T. Hawk. (2002). Chemoprevention of colorectal carcinogenesis. International Journal of Clinical Oncology. 7(1). 2–26. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xianyang Yio Breakdown of academic impact, for papers by Baljinder Salh Breakdown of academic impact, for papers by Jean‐Marie Reimund Breakdown of academic impact, for papers by Ayako Yanai Breakdown of academic impact, for papers by Ya‐Fang Huang Breakdown of academic impact, for papers by Norihiro Hamamoto Breakdown of academic impact, for papers by Romi Ghose Breakdown of academic impact, for papers by Zahra Mojtahedi Breakdown of academic impact, for papers by Olivier Romano Breakdown of academic impact, for papers by Leah M. Flick
Rankless by CCL
2026